Compliance and oversight.
Pioneer Research conducts clinical research in accordance with FDA regulations, ICH Good Clinical Practice, and the requirements of the sponsors and institutional review boards overseeing our studies.
Every study is reviewed before anyone is enrolled
Every study conducted at Pioneer Research is reviewed and approved by an institutional review board before any participant is enrolled. The IRB reviews the protocol, the informed consent document, and any materials used to recruit participants, and provides continuing oversight for the life of the study.
IBC meeting minutes
Pioneer Research makes Institutional Biosafety Committee meeting minutes publicly available in accordance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
Additional minutes are available on request at info@pioneerresearch.com.
A note on how we appear in NIH records
Our Institutional Biosafety Committee is administered by Advarra. The NIH public IBC roster may still list this site under its former name and former location while an administrative update works through NIH’s system. That update was submitted in March 2026 and is administrative only — it does not affect our IBC registration status, protocol reviews, or any ongoing IBC activity.
Questions about oversight?
Ask for the Site Director. We would rather answer it directly than have you guess.